Atlas Trials

Insulin Resistance and Mild Cognitive Impairment (IRMCI) Study

Clinical trial NCT02409238 · TERMINATED

Trial details

NCT number
NCT02409238
Sponsor
SingHealth Polyclinics
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Mild Cognitive ImpairmentInsulin ResistanceDiabetes Mellitus, Type 2
Start date
2015-03-11
Primary completion
2019-12-31
Enrollment
105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.